Veterinary Medicines

Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water

Authorised
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Download as PDF

Product identification

Medicine name:
Lincoral-S 222 mg/g + 444.7 mg/g powder for use in drinking water
Lincoral-s 222+444,7 mg/g pulver til anvendelse i drikkevand
Active substance:
  • Lincomycin hydrochloride monohydrate
  • Spectinomycin sulfate tetrahydrate
Target species:
  • Chicken
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lincomycin hydrochloride monohydrate
    251.70
    milligram(s)
    /
    1.00
    gram(s)
  • Spectinomycin sulfate tetrahydrate
    672.40
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        5
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • 1.5 kg thermos-sealed bags made of polyethylene/aluminum/polyester
  • 150 g thermos-sealed sachets made of polyethylene/aluminum/polyester

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 67188
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0668/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."